Chromatography has long been a bioprocess cornerstone but many platforms today are struggling to keep up with scale, speed, ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...